Wednesday, December 3, 2008 - 1:30AM EST

Review Articles

31. Developmental therapeutics for myelodysplastic syndromes.

Author
Naing A; Sokol L; List AF; Naing A; Sokol L; List AF;
Institution
H. Lee Moffitt Cancer Center & Research Institute, University of South Florida College of Medicine, Tampa, FL, USA.
Journal
J Natl Compr Canc Netw. 2006 Jan;4(1):78-82.
Abstract URL
Click here to view abstract

32. Myelodysplastic syndromes: iron overload consequences and current chelating therapies.

Author
Greenberg PL;
Institution
Hematology Division, Stanford University Cancer Center, 875 Blake Wilbur Drive, Room 2335, Stanford, CA 94305-5821, USA. peterg@stanford.edu
Journal
J Natl Compr Canc Netw. 2006 Jan;4(1):91-6.
Abstract URL
Click here to view abstract

33. Immunomodulatory drugs in myelodysplastic syndromes.

Author
Galili N; Raza A; Galili N; Raza A;
Institution
The Radhey Khanna MDS Center, University of Massachusetts Medical Centre, Division of Hematology, Department of Medicine, 364 Plantation Street, LRB 208, Worcester, MA 01605, USA. naomi.galili@umassmed.edu
Journal
Expert Opin Investig Drugs. 2006 Jul;15(7):805-13.
Abstract URL
Click here to view abstract

34. Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.

Author
List AF; Baker AF; Green S; Bellamy W;
Institution
Malignant Hematology Program, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. listaf@moffitt.org
Journal
Cancer Control. 2006 Dec;13 Suppl:4-11.
Abstract URL
Click here to view abstract

35. Evolving applications of lenalidomide in the management of anemia in myelodysplastic syndromes.

Author
List AF;
Institution
Malignant Hematology Program, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. listaf@moffitt.org
Journal
Cancer Control. 2006 Dec;13 Suppl:12-6.
Abstract URL
Click here to view abstract

36. Myelodysplastic syndromes: the complexity of stem-cell diseases.

Author
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD;
Institution
Department of Leukemia, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. sjcorey@mdanderson.org
Journal
Nat Rev Cancer. 2007 Feb;7(2):118-29.
Abstract URL
Click here to view abstract

37. Evolving classifications of the myelodysplastic syndromes.

Author
Komrokji RS; Bennett JM;
Institution
Department of Medicine, University of Cincinnati and Veterans, Administration Medical Center, Cincinnati, Ohio, USA.
Journal
Curr Opin Hematol. 2007 Mar;14(2):98-105.
Abstract URL
Click here to view abstract

38. The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes.

Author
Melchert M; Kale V; List A;
Institution
Malignant Hematology Division, Department of Medicine, University of South Florida College of Medicine and the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. melcheme@moffitt.usf.edu
Journal
Curr Opin Hematol. 2007 Mar;14(2):123-9.
Abstract URL
Click here to view abstract

39. Umbilical cord blood transplantation for myeloid malignancies.

Author
Brunstein CG; Baker KS; Wagner JE; Brunstein CG; Baker KS; Wagner JE;
Institution
Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota, USA. bruns072@umn.edu
Journal
Curr Opin Hematol. 2007 Mar;14(2):162-9.
Abstract URL
Click here to view abstract

40. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.

Author
Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstocker M; Ruter B; Sperr WR; Stauder R; Wells DA; Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstocker M; Ruter B; Sperr WR; Stauder R; Wells DA;
Institution
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. peter.valent@meduniwien.ac.at
Journal
Leuk Res. 2007 Jun;31(6):727-36. Epub 2007 Jan 25.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6